Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Establishment and some characteristics of epoxomicin (a proteasome inhibitor) resistant variants of the human squamous cell carcinoma cell line, A431.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Establishment and some characteristics of epoxomicin (a proteasome inhibitor) resistant variants of the human squamous cell carcinoma cell line, A431.
Establishment and some characteristics of epoxomicin (a proteasome inhibitor) resistant variants of the human squamous cell carcinoma cell line, A431. Int J Oncol. 2004 Feb; 24(2):425-33.
View in:
PubMed
subject areas
Apoptosis
Blotting, Western
Carcinoma, Squamous Cell
Caspase 3
Caspases
CDC2 Protein Kinase
Cell Division
Cell Line, Tumor
Cyclin B
Cysteine Endopeptidases
Dose-Response Relationship, Drug
Down-Regulation
Electrophoresis, Polyacrylamide Gel
G2 Phase
Humans
Inhibitory Concentration 50
Mitosis
Multienzyme Complexes
Oligopeptides
Peptide Hydrolases
Phosphoric Monoester Hydrolases
Proteasome Endopeptidase Complex
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-cbl
RNA, Messenger
Signal Transduction
Ubiquitin-Conjugating Enzymes
Ubiquitin-Protein Ligases